These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
17. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys. Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S J Virol; 2017 May; 91(10):. PubMed ID: 28250127 [TBL] [Abstract][Full Text] [Related]
18. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses. Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671 [TBL] [Abstract][Full Text] [Related]
19. Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus. Wong G; Qiu X Methods Mol Biol; 2016; 1403():245-57. PubMed ID: 27076134 [TBL] [Abstract][Full Text] [Related]
20. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge. Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]